Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease
about
Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway.Obesity alters molecular and functional cardiac responses to ischemia/reperfusion and glucagon-like peptide-1 receptor agonism.EGFR Inhibition Blocks Palmitic Acid-induced inflammation in cardiomyocytes and Prevents Hyperlipidemia-induced Cardiac Injury in Mice.
P2860
Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease
@en
Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease
@nl
type
label
Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease
@en
Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease
@nl
prefLabel
Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease
@en
Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease
@nl
P2860
P1476
Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease
@en
P2093
Jane A Leopold
P2860
P304
P356
10.1016/J.TCM.2014.09.010
P577
2014-10-02T00:00:00Z